USA - NYSE:TMO - US8835561023 - Common Stock
The current stock price of TMO is 572.5 USD. In the past month the price increased by 23.32%. In the past year, price increased by 3.27%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DHR | DANAHER CORP | 28.92 | 159.69B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 148.65 | 48.49B | ||
| A | AGILENT TECHNOLOGIES INC | 27.16 | 41.97B | ||
| IQV | IQVIA HOLDINGS INC | 19.23 | 37.49B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.07 | 29.55B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 42.07 | 21.39B | ||
| WAT | WATERS CORP | 29.39 | 21.40B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.32 | 17.00B | ||
| ILMN | ILLUMINA INC | 24.06 | 15.39B | ||
| TEM | TEMPUS AI INC | N/A | 15.50B | ||
| ICLR | ICON PLC | 13.5 | 13.85B | ||
| RVTY | REVVITY INC | 20.22 | 11.48B |
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
THERMO FISHER SCIENTIFIC INC
168 Third Avenue
Waltham MASSACHUSETTS 02451 US
CEO: Marc N. Casper
Employees: 125000
Phone: 17816221000
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
The current stock price of TMO is 572.5 USD. The price increased by 0.1% in the last trading session.
THERMO FISHER SCIENTIFIC INC (TMO) has a dividend yield of 0.3%. The yearly dividend amount is currently 1.52.
TMO has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
TMO stock is listed on the New York Stock Exchange, Inc. exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TMO.
You can find the ownership structure of THERMO FISHER SCIENTIFIC INC (TMO) on the Ownership tab.
ChartMill assigns a technical rating of 8 / 10 to TMO. When comparing the yearly performance of all stocks, TMO turns out to be only a medium performer in the overall market: it outperformed 69.5% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to TMO. While TMO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months TMO reported a non-GAAP Earnings per Share(EPS) of 22.4. The EPS increased by 4.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.02% | ||
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| Debt/Equity | 0.62 |
34 analysts have analysed TMO and the average price target is 566.27 USD. This implies a price decrease of -1.09% is expected in the next year compared to the current price of 572.5.
For the next year, analysts expect an EPS growth of 3.97% and a revenue growth 2.82% for TMO